Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome

NCT03337451 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Opsona Therapeutics Ltd.

Collaborators